TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PFE

Pfizer Inc

Healthcare · Drug Manufacturers - General

28.70$ +0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios PFE
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
26.2 42.1 46.5 61.1 74.6 30.8 19.9 62.4 17.1 21.5 16.2 18.2 14.1 14.1 16.2 18.5 18.3 17.2 4.2 5.5 5.3 2.0 22.2 13.0 22.6 15.2 9.4 77.1 18.8 18.2
4.5 7.5 11.5 12.0 9.4 7.4 5.6 5.4 3.7 3.5 3.7 3.1 2.3 2.4 2.0 2.6 3.3 3.9 0.8 0.8 0.7 0.8 4.6 5.1 5.0 4.1 2.9 2.8 2.4 2.3
7.3 11.8 17.7 21.9 17.3 13.1 9.1 3.7 2.8 2.5 2.5 2.3 2.0 1.4 1.5 2.0 2.2 2.6 0.5 0.6 0.6 0.6 3.9 3.3 3.3 4.4 3.1 1.8 1.7 1.6
4.6 7.6 11.6 12.2 9.5 7.7 5.9 5.7 4.0 3.8 3.8 3.3 2.7 3.4 2.6 3.2 3.8 4.5 1.4 1.5 1.5 1.6 5.4 6.4 5.9 4.6 3.3 3.9 3.4 3.3
16.7 27.0 25.5 25.1 29.6 21.4 14.4 17.9 10.9 10.7 9.8 10.7 8.4 10.0 9.0 8.9 10.1 10.0 3.7 4.8 5.1 4.2 14.7 13.9 18.6 12.1 8.0 24.4 11.8 13.6
39.2 135.9 89.9 129.9 69.4 34.0 21.5 26.8 14.1 13.0 11.5 13.0 6.9 7.9 13.5 8.7 11.4 12.3 2.5 2.9 2.7 2.9 18.2 21.1 17.8 11.3 11.3 34.3 15.4 15.6
2.6% 0.7% 1.1% 0.8% 1.4% 2.9% 4.6% 3.7% 7.1% 7.7% 8.7% 7.7% 14.6% 12.6% 7.4% 11.5% 8.8% 8.1% 40.2% 33.9% 36.6% 34.3% 5.5% 4.7% 5.6% 8.9% 8.9% 2.9% 6.5% 6.4%
Margins
84.6% 85.8% 88.1% 87.7% 86.3% 84.4% 87.5% 78.2% 79.2% 77.8% 78.3% 75.8% 79.2% 76.8% 69.1% 71.9% 73.2% 72.9% 73.2% 73.1% 69.8% 70.0% 70.2% 69.3% 71.7% 57.7% 61.9% 50.9% 65.8% 70.3%
27.2% 26.8% 26.6% 28.1% 29.3% 34.0% 37.9% 23.9% 32.5% 30.7% 31.2% 28.7% 34.4% 32.0% 26.4% 30.1% 33.0% 32.7% 28.3% 27.2% 27.0% 27.4% 28.5% 18.2% 21.8% 25.6% 37.4% 8.9% 25.9% 24.7%
17.1% 17.7% 24.7% 19.6% 12.6% 24.1% 28.2% 8.7% 21.6% 16.1% 22.8% 17.0% 16.6% 17.3% 12.3% 14.3% 17.9% 22.6% 18.3% 14.3% 13.7% 40.5% 20.8% 39.5% 22.0% 27.2% 31.3% 3.6% 12.6% 12.4%
11.4% 5.5% 12.8% 9.2% 13.5% 21.9% 26.0% 20.1% 26.2% 26.6% 32.1% 23.7% 34.2% 30.8% 14.8% 30.4% 28.8% 31.6% 30.8% 26.6% 26.3% 27.1% 25.4% 24.3% 27.9% 36.7% 25.9% 8.0% 15.5% 14.5%
Returns
27.7% 27.9% 38.0% 35.8% 23.2% 42.6% 45.7% 6.0% 16.6% 11.6% 15.4% 12.6% 13.9% 9.6% 9.4% 10.6% 12.0% 15.3% 12.7% 10.7% 12.1% 29.7% 17.5% 25.6% 14.4% 28.6% 32.7% 2.4% 9.1% 9.0%
13.2% 14.4% 18.3% 15.5% 11.1% 19.9% 19.7% 3.3% 9.2% 6.5% 9.6% 7.1% 7.2% 4.1% 4.2% 4.6% 5.3% 6.8% 5.4% 4.2% 4.2% 12.4% 7.0% 9.7% 5.9% 12.2% 15.9% 0.9% 3.8% 3.7%
Balance Sheet & Debt
1,085 1,374 1,177 2,941 4,313 7,836 9,931 13,053 16,737 15,689 6,153 9,733 15,161 46,684 42,298 35,765 27,379 34,306 33,339 35,337 39,491 42,136 40,606 50,840 38,052 36,492 35,413 68,523 62,962 63,149
0.3 0.4 0.2 0.4 0.5 0.7 0.7 0.9 0.9 0.9 0.3 0.7 1.0 2.8 2.2 1.6 1.3 1.5 1.7 2.3 2.6 2.1 2.1 2.7 2.9 1.2 0.9 7.2 3.5 4.2
47.4% 51.7% 48.1% 43.2% 48.0% 46.7% 43.0% 56.0% 55.2% 55.8% 62.1% 56.4% 51.8% 42.3% 45.0% 43.7% 43.7% 44.3% 42.3% 38.8% 34.9% 41.7% 40.0% 37.9% 41.2% 42.7% 48.6% 39.4% 41.3% 41.5%
0.3 0.3 0.3 0.6 0.3 0.5 0.6 0.2 0.3 0.3 0.1 0.2 0.3 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.7 0.6 0.7 0.8 0.6 0.5 0.4 0.8 0.7 0.7
Per Share
0.50 0.56 0.85 0.50 0.59 1.22 1.46 0.54 1.49 1.03 1.52 1.18 1.19 1.23 1.02 1.11 1.30 1.69 7.07 5.57 5.86 17.58 1.87 2.87 1.63 3.88 5.47 0.37 1.41 1.37
2.93 3.16 3.44 2.57 4.64 5.07 5.19 6.20 6.90 6.40 6.65 6.98 7.15 7.10 8.31 7.76 7.28 7.48 38.61 39.04 42.88 43.37 8.98 7.25 7.40 14.24 17.50 10.43 11.16 11.01
1.80 2.01 2.24 1.41 2.52 2.88 3.20 8.97 8.97 8.86 9.81 9.37 8.53 12.78 10.88 10.44 10.82 11.07 55.75 51.94 48.58 59.14 10.67 11.18 11.27 13.57 16.73 15.64 15.47 15.21
0.34 0.17 0.44 0.24 0.63 1.11 1.35 1.25 1.80 1.70 2.14 1.65 2.45 2.18 1.23 2.36 2.09 2.36 11.91 10.40 11.29 11.76 2.28 1.76 2.06 5.23 4.54 0.84 1.73 1.60

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?